Extremely prolonged HIV seroconversion associated with an MHC haplotype carrying disease susceptibility genes for antibody deficiency disorders

Extremely prolonged HIV seroconversion associated with an MHC haplotype carrying disease susceptibility genes for antibody deficiency disorders

Copyright © 2010 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 137(2010), 2 vom: 07. Nov., Seite 199-208
1. Verfasser: Padiglione, Alex (VerfasserIn)
Weitere Verfasser: Aleksic, Eman, French, Martyn, Arnott, Alicia, Wilson, Kim M, Tippett, Emma, Kaye, Matthew, Gray, Lachlan, Ellett, Anne, Crane, Megan, Leslie, David E, Lewin, Sharon R, Breschkin, Alan, Birch, Chris, Gorry, Paul R, McPhee, Dale A, Crowe, Suzanne M
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2010
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Case Reports Journal Article Research Support, Non-U.S. Gov't Antibodies Antibodies, Neutralizing HIV Antigens HIV Core Protein p24 Hepatitis A Vaccines Hepatitis B Vaccines Immunoglobulin G mehr... Influenza Vaccines RNA, Viral Receptors, CCR5
LEADER 01000naa a22002652 4500
001 NLM200193384
003 DE-627
005 20231223220104.0
007 cr uuu---uuuuu
008 231223s2010 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2010.07.003  |2 doi 
028 5 2 |a pubmed24n0667.xml 
035 |a (DE-627)NLM200193384 
035 |a (NLM)20696618 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Padiglione, Alex  |e verfasserin  |4 aut 
245 1 0 |a Extremely prolonged HIV seroconversion associated with an MHC haplotype carrying disease susceptibility genes for antibody deficiency disorders 
264 1 |c 2010 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 17.02.2011 
500 |a Date Revised 25.11.2016 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2010 Elsevier Inc. All rights reserved. 
520 |a Severe immunodeficiency during primary human immunodeficiency virus (HIV) infection is unusual. Here, we characterized viral and immunological parameters in a subject presenting with Pneumocystis jirovecii pneumonia in the setting of prolonged primary HIV illness and delayed seroconversion. HIV antibody was only detected by enzyme-linked immunosorbent assay 12 months after presentation, and Western blot profiles remain indeterminate. Isolated virus was of R5 phenotype, exhibited poor viral fitness, but was otherwise unremarkable. Analysis of HIV antibody isotypes showed failure to mount a detectable HIV IgG response over nearly 2 years of infection, in particular IgG(1)- and IgG(3)-specific responses, despite normal responses to common infections and vaccines. Genetic analysis demonstrated homozygosity for part of an MHC haplotype containing susceptibility genes for common variable immunodeficiency (CVID) syndrome and other antibody deficiency disorders. Thus, a primary disorder of specific antibody production may explain exceptionally slow antibody development in an otherwise severe seroconversion illness. This highlights the need for multiparameter testing, in particular use of a fourth generation HIV test, for confirming HIV infection and underscores the importance of host factors in HIV pathogenesis 
650 4 |a Case Reports 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a Antibodies  |2 NLM 
650 7 |a Antibodies, Neutralizing  |2 NLM 
650 7 |a HIV Antigens  |2 NLM 
650 7 |a HIV Core Protein p24  |2 NLM 
650 7 |a Hepatitis A Vaccines  |2 NLM 
650 7 |a Hepatitis B Vaccines  |2 NLM 
650 7 |a Immunoglobulin G  |2 NLM 
650 7 |a Influenza Vaccines  |2 NLM 
650 7 |a RNA, Viral  |2 NLM 
650 7 |a Receptors, CCR5  |2 NLM 
700 1 |a Aleksic, Eman  |e verfasserin  |4 aut 
700 1 |a French, Martyn  |e verfasserin  |4 aut 
700 1 |a Arnott, Alicia  |e verfasserin  |4 aut 
700 1 |a Wilson, Kim M  |e verfasserin  |4 aut 
700 1 |a Tippett, Emma  |e verfasserin  |4 aut 
700 1 |a Kaye, Matthew  |e verfasserin  |4 aut 
700 1 |a Gray, Lachlan  |e verfasserin  |4 aut 
700 1 |a Ellett, Anne  |e verfasserin  |4 aut 
700 1 |a Crane, Megan  |e verfasserin  |4 aut 
700 1 |a Leslie, David E  |e verfasserin  |4 aut 
700 1 |a Lewin, Sharon R  |e verfasserin  |4 aut 
700 1 |a Breschkin, Alan  |e verfasserin  |4 aut 
700 1 |a Birch, Chris  |e verfasserin  |4 aut 
700 1 |a Gorry, Paul R  |e verfasserin  |4 aut 
700 1 |a McPhee, Dale A  |e verfasserin  |4 aut 
700 1 |a Crowe, Suzanne M  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 137(2010), 2 vom: 07. Nov., Seite 199-208  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:137  |g year:2010  |g number:2  |g day:07  |g month:11  |g pages:199-208 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2010.07.003  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 137  |j 2010  |e 2  |b 07  |c 11  |h 199-208